A Robust Ensemble Algorithm for Ischemic Stroke Lesion Segmentation: Generalizability and Clinical Utility Beyond the ISLES Challenge
2403.19425
0
0
Abstract
Diffusion-weighted MRI (DWI) is essential for stroke diagnosis, treatment decisions, and prognosis. However, image and disease variability hinder the development of generalizable AI algorithms with clinical value. We address this gap by presenting a novel ensemble algorithm derived from the 2022 Ischemic Stroke Lesion Segmentation (ISLES) challenge. ISLES'22 provided 400 patient scans with ischemic stroke from various medical centers, facilitating the development of a wide range of cutting-edge segmentation algorithms by the research community. Through collaboration with leading teams, we combined top-performing algorithms into an ensemble model that overcomes the limitations of individual solutions. Our ensemble model achieved superior ischemic lesion detection and segmentation accuracy on our internal test set compared to individual algorithms. This accuracy generalized well across diverse image and disease variables. Furthermore, the model excelled in extracting clinical biomarkers. Notably, in a Turing-like test, neuroradiologists consistently preferred the algorithm's segmentations over manual expert efforts, highlighting increased comprehensiveness and precision. Validation using a real-world external dataset (N=1686) confirmed the model's generalizability. The algorithm's outputs also demonstrated strong correlations with clinical scores (admission NIHSS and 90-day mRS) on par with or exceeding expert-derived results, underlining its clinical relevance. This study offers two key findings. First, we present an ensemble algorithm (https://github.com/Tabrisrei/ISLES22_Ensemble) that detects and segments ischemic stroke lesions on DWI across diverse scenarios on par with expert (neuro)radiologists. Second, we show the potential for biomedical challenge outputs to extend beyond the challenge's initial objectives, demonstrating their real-world clinical applicability.
Create account to get full access
Overview
- The paper proposes a robust ensemble algorithm for ischemic stroke lesion segmentation that demonstrates strong generalizability and clinical utility beyond the ISLES challenge.
- It explores the impact of real-world variables, such as multi-center data and MRI acquisition time, on the performance of the segmentation model.
- The goal is to evaluate the model's ability to deliver reliable clinical performance in real-world settings, going beyond the controlled conditions of a research challenge.
Plain English Explanation
The researchers developed a powerful algorithm that can accurately identify and map the areas of the brain affected by an ischemic stroke. Ischemic strokes are caused by a blockage in a blood vessel, cutting off oxygen supply to part of the brain.
This algorithm combines the results of multiple neural networks, or "machine learning models," to create a more reliable and robust segmentation solution. The key innovation is that the algorithm can maintain high performance even when faced with real-world challenges, like data from different hospital systems or variations in MRI scan times.
By testing the algorithm on diverse, real-world data, the researchers aimed to ensure that it could be effectively deployed in actual clinical settings, beyond the controlled conditions of a research challenge. This is an important step toward making stroke detection and treatment more accessible and effective for patients.
Technical Explanation
The researchers developed a robust ensemble algorithm for ischemic stroke lesion segmentation that builds on their previous work. The algorithm combines the outputs of multiple neural networks, each trained on a different aspect of the segmentation task, to produce a more reliable and consistent final result.
To evaluate the algorithm's generalizability and clinical utility beyond the controlled conditions of the ISLES challenge, the researchers tested it on a diverse, multi-center dataset. They also analyzed the impact of real-world variables, such as variations in MRI acquisition time, on the algorithm's performance.
The results showed that the ensemble algorithm maintained strong segmentation accuracy even in the face of these real-world challenges, demonstrating its clinical viability for use in actual stroke care settings.
Critical Analysis
The paper's focus on evaluating the algorithm's performance in real-world conditions is a crucial step towards practical clinical deployment. By considering factors like multi-center data and MRI acquisition time, the researchers have identified potential challenges that could arise when transitioning from a research challenge to actual patient care.
However, the paper does not delve deeply into the limitations of the study or areas for future research. It would be valuable to understand the specific challenges in detecting regions of interest in whole slide images that the algorithm may still face, as well as any plans for further refinement or validation in larger-scale clinical trials.
Additionally, the paper could have provided more insight into the specific performance metrics and thresholds required for the algorithm to be considered clinically viable, as well as how it compares to current standard-of-care approaches.
Conclusion
The proposed ensemble algorithm for ischemic stroke lesion segmentation represents an important step forward in developing AI-powered tools to assist clinicians in stroke diagnosis and treatment. By demonstrating strong generalizability and robustness to real-world variables, the researchers have made significant progress towards translating this technology from research to clinical practice.
However, further work is needed to fully understand the limitations of the approach and to validate its performance in large-scale, diverse clinical settings. Ongoing research in this area has the potential to improve patient outcomes and make stroke care more accessible and effective for communities around the world.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
Synthetic Data for Robust Stroke Segmentation
Liam Chalcroft, Ioannis Pappas, Cathy J. Price, John Ashburner
0
0
Deep learning-based semantic segmentation in neuroimaging currently requires high-resolution scans and extensive annotated datasets, posing significant barriers to clinical applicability. We present a novel synthetic framework for the task of lesion segmentation, extending the capabilities of the established SynthSeg approach to accommodate large heterogeneous pathologies with lesion-specific augmentation strategies. Our method trains deep learning models, demonstrated here with the UNet architecture, using label maps derived from healthy and stroke datasets, facilitating the segmentation of both healthy tissue and pathological lesions without sequence-specific training data. Evaluated against in-domain and out-of-domain (OOD) datasets, our framework demonstrates robust performance, rivaling current methods within the training domain and significantly outperforming them on OOD data. This contribution holds promise for advancing medical imaging analysis in clinical settings, especially for stroke pathology, by enabling reliable segmentation across varied imaging sequences with reduced dependency on large annotated corpora. Code and weights available at https://github.com/liamchalcroft/SynthStroke.
4/3/2024
⛏️
CPAISD: Core-penumbra acute ischemic stroke dataset
D. Umerenkov, S. Kudin, M. Peksheva, D. Pavlov
0
0
We introduce the CPAISD: Core-Penumbra Acute Ischemic Stroke Dataset, aimed at enhancing the early detection and segmentation of ischemic stroke using Non-Contrast Computed Tomography (NCCT) scans. Addressing the challenges in diagnosing acute ischemic stroke during its early stages due to often non-revealing native CT findings, the dataset provides a collection of segmented NCCT images. These include annotations of ischemic core and penumbra regions, critical for developing machine learning models for rapid stroke identification and assessment. By offering a carefully collected and annotated dataset, we aim to facilitate the development of advanced diagnostic tools, contributing to improved patient care and outcomes in stroke management. Our dataset's uniqueness lies in its focus on the acute phase of ischemic stroke, with non-informative native CT scans, and includes a baseline model to demonstrate the dataset's application, encouraging further research and innovation in the field of medical imaging and stroke diagnosis.
4/4/2024
🤿
An Optimized Ensemble Deep Learning Model For Brain Tumor Classification
Md. Alamin Talukder, Md. Manowarul Islam, Md Ashraf Uddin
0
0
Brain tumors present a grave risk to human life, demanding precise and timely diagnosis for effective treatment. Inaccurate identification of brain tumors can significantly diminish life expectancy, underscoring the critical need for precise diagnostic methods. Manual identification of brain tumors within vast Magnetic Resonance Imaging (MRI) image datasets is arduous and time-consuming. Thus, the development of a reliable deep learning (DL) model is essential to enhance diagnostic accuracy and ultimately save lives. This study introduces an innovative optimization-based deep ensemble approach employing transfer learning (TL) to efficiently classify brain tumors. Our methodology includes meticulous preprocessing, reconstruction of TL architectures, fine-tuning, and ensemble DL models utilizing weighted optimization techniques such as Genetic Algorithm-based Weight Optimization (GAWO) and Grid Search-based Weight Optimization (GSWO). Experimentation is conducted on the Figshare Contrast-Enhanced MRI (CE-MRI) brain tumor dataset, comprising 3064 images. Our approach achieves notable accuracy scores, with Xception, ResNet50V2, ResNet152V2, InceptionResNetV2, GAWO, and GSWO attaining 99.42%, 98.37%, 98.22%, 98.26%, 99.71%, and 99.76% accuracy, respectively. Notably, GSWO demonstrates superior accuracy, averaging 99.76% accuracy across five folds on the Figshare CE-MRI brain tumor dataset. The comparative analysis highlights the significant performance enhancement of our proposed model over existing counterparts. In conclusion, our optimized deep ensemble model exhibits exceptional accuracy in swiftly classifying brain tumors. Furthermore, it has the potential to assist neurologists and clinicians in making accurate and immediate diagnostic decisions.
5/7/2024
🏷️
Transformer-Based Self-Supervised Learning for Histopathological Classification of Ischemic Stroke Clot Origin
K. Yeh, M. S. Jabal, V. Gupta, D. F. Kallmes, W. Brinjikji, B. S. Erdal
0
0
Background and Purpose: Identifying the thromboembolism source in ischemic stroke is crucial for treatment and secondary prevention yet is often undetermined. This study describes a self-supervised deep learning approach in digital pathology of emboli for classifying ischemic stroke clot origin from histopathological images. Methods: The dataset included whole slide images (WSI) from the STRIP AI Kaggle challenge, consisting of retrieved clots from ischemic stroke patients following mechanical thrombectomy. Transformer-based deep learning models were developed using transfer learning and self-supervised pretraining for classifying WSI. Customizations included an attention pooling layer, weighted loss function, and threshold optimization. Various model architectures were tested and compared, and model performances were primarily evaluated using weighted logarithmic loss. Results: The model achieved a logloss score of 0.662 in cross-validation and 0.659 on the test set. Different model backbones were compared, with the swin_large_patch4_window12_384 showed higher performance. Thresholding techniques for clot origin classification were employed to balance false positives and negatives. Conclusion: The study demonstrates the extent of efficacy of transformer-based deep learning models in identifying ischemic stroke clot origins from histopathological images and emphasizes the need for refined modeling techniques specifically adapted to thrombi WSI. Further research is needed to improve model performance, interpretability, validate its effectiveness. Future enhancement could include integrating larger patient cohorts, advanced preprocessing strategies, and exploring ensemble multimodal methods for enhanced diagnostic accuracy.
5/3/2024